FullerRLFeigenbaumPLaPelleN, et al.Functional Rating Scale 2.0 (FuRST 2.0): a patient-reported outcome measure of function for Huntington’s disease. J Huntingtons Dis2025; 14: 171–178.
2.
BrumfieldOSZizziCEDilekN, et al.The Huntington's disease health index: initial evaluation of a disease-specific patient reported outcome measure. J Huntingtons Dis2022; 11: 217–226.
3.
Furr StimmingEClaassenDOKaysonE, et al.Huntington Study Group KINECT-HD Collaborators. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Neurol2023 Jun; 22: 494–504. Erratum in: Lancet Neurol. 2023 Sep;22(9):e10. doi: 10.1016/S1474-4422(23)00279-X. Erratum in: Lancet Neurol. 2023 Sep;22(9):e10. doi: 10.1016/S1474-4422(23)00282-X. PMID: 37210099
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
